The founding scientists of GNT Pharma have delineated mechanisms underlying nerve cell death occurring in stroke, trauma, and neurodegenerative diseases and discovered therapeutic targets for the interventional therapy that is for medical unmet needs. The drug candidates of GNT Pharma were derived from novel findings that aspirin and sulfasalazine, salicylate derivatives widely used for the treatment of inflammatory diseases, protected neurons as a low affinity NMDA receptor antagonist and antioxidant. Through the rational drug design, GNT Pharma discovered chemical structures essential for neuroprotective effects and has established chemical libraries with promising efficacy and safety that are enough to advance to clinical stage.
View Top Employees from GNT Pharma Co., LtdWebsite | http://gntpharma.com/en/home_en/ |
Revenue | $3 million |
Employees | 7 (5 on RocketReach) |
Address | 1855-23 Yongudae-ro Giheung-gu Yeongtong-gu, Yongin, Chungcheongnam-do, KR |
Phone | +82 31-8005-9910 |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular GNT Pharma Co., Ltd employee's phone or email?
The GNT Pharma Co., Ltd annual revenue was $3 million in 2024.
5 people are employed at GNT Pharma Co., Ltd.
GNT Pharma Co., Ltd is based in Yongin, Chungcheongnam-do.
The NAICS codes for GNT Pharma Co., Ltd are [32, 32541, 325, 3254].
The SIC codes for GNT Pharma Co., Ltd are [283, 28].